搜索
Aytu Biopharma Inc
AYTU添加自选
2.230USD
+0.080+3.72%
收盘 07-31 16:00（美东）报价延迟15分钟
23.94M总市值
亏损市盈率 TTM
关于 Aytu Biopharma Inc 公司
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Aytu Biopharma Inc简介
公司代码AYTU
公司名称Aytu Biopharma Inc
上市日期Oct 20, 2017
CEODisbrow (Joshua R)
员工数量82
证券类型Ordinary Share
年结日Oct 20
公司地址7900 E. Union Avenue
城市DENVER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编80237
电话17204376580
网址https://aytubio.com/
公司代码AYTU
上市日期Oct 20, 2017
CEODisbrow (Joshua R)
Aytu Biopharma Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
常见问题
Aytu Biopharma Inc的前五大股东是谁？
Aytu Biopharma Inc 的前五大股东如下：Mr. Jarrett T. (Josh) Disbrow
有多少机构持有Aytu Biopharma Inc(AYTU)的股份？
截至2026Q1，共有69家机构持有Aytu Biopharma Inc的股份，合计持有的股份价值约为3.87M，占公司总股份的36.10%。与2025Q4相比，机构持股有所增加，增幅为-493525.00。
哪个业务部门对Aytu Biopharma Inc的收入贡献最大？
在2026Q1，ADHD portfolio业务部门对Aytu Biopharma Inc的收入贡献最大，创收13.22M，占总收入的87.15%。